Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry

• Main Authors: Rodrigo R. R. Duarte (Author), Dennis C. Copertino (Author), Luis P. Iñiguez (Author), Jez L. Marston (Author), Yaron Bram (Author), Yuling Han (Author), Robert E. Schwartz (Author), Shuibing Chen (Author), Douglas F. Nixon (Author), Timothy R. Powell (Author)
• Format: Book
• Published: BMC, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Vaccination programs have been launched worldwide to halt the spread of COVID-19. However, the identification of existing, safe compounds with combined treatment and prophylactic properties would be beneficial to individuals who are waiting to be vaccinated, particularly in less...